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1. Introduction 
The testicular mesothelioma is one of the rare tumor from other types of mesotheliomas 
(less than 1%)[9, 43, 81, 104]. In light of this are clear of the difficulties encountered by 
some clinicians, radiologists, pathologists and cytologists in differential diagnosis. In 
addition, they are so rare that there is no more the researcher, which would focus in his 
hands a sufficient number of his own observations to make serious conclusions. That is 
why, apparently, the question of the tumor so far in the literature are not systematically 
developed. The lack of sufficient information on the morphology of mesothelioma are 
often a cause of incorrect diagnosis. It should also be recognized that a lack of sufficient 
morphological data about testicular mesothelioma considerably narrows the diagnostic 
possibilities for dissector and thereby restricts the advice assistant to clinic in establishing 
the correct diagnosis. In this regard, it seems appropriate to offer for the attention of 
specialists is one of the literary reviews, focusing on the pathological anatomy of this 
enigmatic tumor, thereby making an attempt to systematize to some extent, knowledge of 
mesothelial tumors. We hope that the proposed work will be useful and necessary in the 
daily work of professionals and will be of interest for researchers studying and 
developing one of the important problems in oncology - the problem of testicular 
mesothelioma. 
2. Synonyms and definition 
Testicular mesothelioma is one of the testis-specific and aggressive form of cancer that 
develops from the mesothelium covering the tunica albuginea as well as parietal and 
visceral sheets of the tunica vaginalis of the testis, epididymis, and spermatic cord, and 
surrounding it, thereby providing protection and support of this body [68, 79]. Among the 
primary tumors of serous integument mesothelioma (synonyms: adenofibroma, 
adenofibromyoma, adenoma, adenoma of Müllerian moves, adenomatoid genital tract 
tumor, adenomatoid leiomyoma, adenomatoid tumor, adenomatous tumor, angiomatoid 
tumor, angiomatoid tumor of endothelium, cancerous endothelioma, carcinosarcoma, 
celomic cancer, celothelioma, cystadenoma, endothelial cancer, endothelioma, 
fibroadenoma, lymfangioendothelioma, lymphangioma, malignant epithelioma, malignant 
epithelioma of serosa, malignant tumor of the serous covering of cells, primary carcinoma, 
sarcomatous endothelioma) of the testis is a relatively rare [49, 96, 99].  
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3. Epidemiology: Frequency and age 
Considered a type of cancer in this chapter is most common with a high socio-economic 
status, mainly in the elderly, but is in young and even in the children, and the incidence has 
two peaks: the first in 20-30 years, the second after 50 years [110]. Testicular tumors are 
about 1% of the total number of tumors in men [25]. They occur with a frequency of 20-25 
per 1 million men, most aged 20-35 years (3, 40). Testicular tumors in 60% of the 
observations affect the boys up to 3 years of age, with 80% of them are malignant [5, 60, 67] . 
The high incidence of testicular tumors for 1998-2002 is registered in most countries of 
Western Europe: Denmark (9.2 per 100 000 population), Germany (8.1), Scotland (7.6), Italy 
(7.3), Switzerland (6.9), Czech Republic (6. 5), Netherlands (6.0), Russia, St. Petersburg (1.7); 
among the white U.S. population (6.0-6.8) [110]. Throughout the second half of the last 
century there has been an increase of morbidity by testicular cancer. In 2002 in Russia 
revealed 1189 testicular cancer, representing 1.8 per 100 000 population[64]. Most often, 
these tumors were observed in age from 0 to 4 years, 30 to 34 years and older than 75 years. 
The countries with high mortality (> 0.5) from testicular cancer are almost all represented by 
the WHO the countries of Eastern and Central Europe (Croatia, Czech Republic, Estonia, 
Hungary, Latvia, Lithuania, Poland, Romania, Slovakia, Slovenia, etc.) [44, 71]. In Western 
Europe and the U.S., that is, in regions with a high morbidity of testicular cancer, the 
mortality rate is low, which can be attributed to advances in the treatment of tumors of the 
body. Mortality, respectively, is low and in countries with low morbidity, namely in East 
Asia. In Russia, the mortality statistics from testicular cancer is not provided and there is 
still no national registry of mesothelioma.  
However, Kashansky [51] in Russia for the period from 1881 to 2006 has conducted a time-
consuming retrospective analysis of published by Russian-speaking authors of 872 papers 
containing descriptions of 3576 observations of mesotheliomas in different locations, 
including 29 (0.8%) - of testis, but without a clear representation of literary references 
proving the obtained data that undoubtedly reduces the quality of his work. The decrease of 
the reliability of this work also can be attributed to a lack of the Russian national 
mesothelioma registry. Currently, the epidemiology of the disease being studied in the Altai 
Territory and the Sverdlovsk region of Russia, and the mesothelioma monitoring was 
organized in St. Petersburg.  
According to Butnor, et al [15] revealed 80 observations of paratesticular adenomatoid 
tumor, and Murai [78] reports only 6 (0.3%) cases of malignant mesothelioma from 1785 of 
mesotheliomas of various localizations during 1958-1996, arising from the tunica vaginalis 
of testes.  
Testicular mesothelioma occurs at various ages, from newborns to 80 years. Over the past 50 
years, have been documented about 100 cases of testicular mesothelioma [113]. About 80 
cases of malignant testicular mesothelioma are reported in the literature, and the frequency 
of mesothelioma is 1: 1 000 000 [43]. Al-Qahtani, et al. [4] indicate that 73 surveillances of 
malignant mesothelioma arising from the testicular serous membranes, are published in the 
literature for the period 1966-1997. Mesothelioma varies in a wide range from 0.6 cases per 1 
million inhabitants per year in Tunisia, and 35 in Australia [63]. The background morbidity 
is 1-2 cases per 1 million of population per year (39). According to forecasts Peto, et al. [84] 
the mortality from mesothelioma in Western European countries will grow from 5,000 cases 
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in 1998 to 9,000 in 2018 and over the next 35 years from mesothelioma dies about 250 000 
people. 
According to the International Agency for Research on Cancer, in Europe there is a 
significant variation between the levels of mesothelioma morbidity in different countries 
[10, 110]. Thus, in 1993-1997 the largest number of cases of mesothelioma among men are 
registered in Scotland and the Netherlands - 34 cases per million, whereas in Estonia and 
Belarus - only 3 cases per million. The situation with the frequency of detection of 
mesothelioma in the USA and Canada is different from Australia, France and Great Britain, 
where the number of cases is much higher and continues to grow [85]. For example, in 
Australia in 1993-1997 were recorded an average of 23 cases with mesothelioma per million 
among men. In 2000, there were already 60 cases per million in men [45].  
Among the economically developed countries of Western Europe, only in Sweden is a 
similar situation to the United States. In 1993-1997 the morbidity among Swedish men was 
at the level of the13 cases per million population, but in recent years, the downward trend of 
these indicators. Projected to peak IARC mesothelioma in Western Europe will be in the 
2015-2030 years. According to the International Agency for Research on Cancer the peak of 
mesothelioma morbidity in Western Europe will be in the 2015-2030 [11, 110].  
 Thus, epidemiological data about this type of cancer are inconsistent and is explained by 
the fact that some authors consider the testicular tumors with the positions of germ cell 
tumors, not considering the mesothelioma of the paratesticular zone, other researchers lead 
only statistics of the mesotheliomas of other more frequent localizations, not focusing its 
attention on the testicular mesothelioma because of its great rarity, and numerous 
publications on the paratesticular mesothelioma are, unfortunately, mostly descriptive in 
nature. That is why out of the contradictory situation is advisable to establish national 
centers of pathology with the formation of these cytology, biopsy and autopsy banks, 
followed by an examination of questions of etiology, epidemiology, patho-and 
morphogenesis of tumor diseases and, in particular, testicular mesothelioma, as well as 
analysis of the intravital diagnosis of pathological processes in order to the timely treatment 
and prevention [116].  
4. Etiology and pathogenesis  
The exact cause of the testicular mesothelioma is not installed, but the known risk factors 
that may contribute to its development [20, 64]. Factors of the testicular tumors are as 
follows: 1. Age. The majority of cases of the testicular cancer are detected from 15 to 40 
years. However, the tumor may occur at any age, including infants and the elderly. 2. 
Cryptorchidism, in which the possibility of the tumor defeat is growing at 40-60 times. 3. 
Professional career: the miners, firefighters, utility workers, leather, printing, oil and gas 
industry have an increased risk of testicular cancer. Rather, it involves the use of certain 
solvents and dyes. Therefore, the risk group usually consists of firefighters, miners, 
plumbers, builders and gasman. 4. AIDS. Men living with human immunodeficiency virus, 
there is an increased role in the development of the testicular cancer. 5. Race. The probability 
of occurrence of the testicular cancer among white Americans is 5-10 times higher than 
among African-American men. The risk of the testicular cancer in men of Asia and Africa is 
low. 6. Nutrition. The excessive consumption of animal fat is a risk factor for the testicular 
www.intechopen.com
Mesotheliomas – Synonyms and Definition, Epidemiology, Etiology,  
Pathogenesis, Cyto-Histopathological Features, Clinic, Diagnosis, Treatment, Prognosis 
 
52
cancer. 7. A small increase in risk of the testicular cancer is associated with the trauma of the 
scrotum. 8. The risk of the testicular cancer raised among young people whose mothers used 
to maintain the pregnancy is estrogenic drugs, in particular, diethylstilbestrol, and who 
were, respectively, in vitro exposed to estrogens.  
In recent years actively accumulates information indicating about polyetiology of the 
disease [83]. There is increasing works on mesothelial activity of chemical (salts of nickel, 
beryllium, silica, tobacco, iron oxide, manganese, carbon black, polyurethane, polysilicon, 
ethylene oxide, wollastonite, erionite, etc.), physical (microwave and ionizing radiation) and 
biological (fungi , mycobacterium tuberculosis, viruses of the avian leukemia (MS 29) and 
simian virus 40) agents [30, 37, 42, 77, 82, 111]. Presently, a considerable role in the 
development of mesothelioma is assigned to viral etiology, with the Simian virus 40 being 
isolated in 47-83% of human mesotheliomas, yet the currently available epidemiological 
evidence seems insufficient to duly evaluate the impact of this virus on the increased 
incidence of mesothelioma in the second half of the last century [17, 20]. Among the 
carcinogenic factors contributing to the emergence of mesothelioma, the asbestos is in the 
first place, especially the impact of asbestos and its derivatives (actinolite, zeolite, amosite, 
anthophyllite, chrysotile, crocidolite and tremolite), which are classified by the International 
Agency for Research on Cancer in Group 1 of the carcinogen risk to human where asbestos 
can be both a stimulant and an initiator of carcinogenesis, it has its own cancer-causing 
properties and, moreover, can enhance the carcinogenic effect of other factors [12, 33, 62, 90]. 
Like all other types of mesothelioma, testicular mesothelioma is believed to be caused by 
exposure to asbestos [7, 87]. In 40% of patients had contact with asbestos, and notes the 
synergy effects of smoking and asbestos at risk of developing mesothelioma [43]. Despite 
the fact that in some developed countries reduces production and use of asbestos, the 
morbidity and mortality from mesothelioma continues to rise. This can be explained to the 
delayed effect of asbestos. It is known that for development of malignant tumor the latency 
period is required, the duration of which depends from the carcinogenic factor could be 20 
years or more. However, it is possible that increases in the morbidity of mesothelioma is 
related to other unknown factors [29, 32]. Since the beginning of 1970 in the XX century in 
Western countries, the development of mesothelioma were due solely to the inhalation of 
asbestos-containing dust, and, above all, amphibole asbestos, especially crocidolite, and 
tremolite asbestos, which currently have a crucial role in the etiology of the disease [22, 36]. 
Human exposure occurs through inhalation of asbestos fibers from the polluted air in the 
working environment, as well as from the ambient air near of the sources of such pollution, 
or in rooms that contain the fragile asbestos materials. Such exposure may occur during the 
installation and use of asbestos-containing materials, and of the vehicle maintenance. In 
1977 in Germany, then in France, Japan, Finland, USA and other countries, and since 1996 in 
Russia the mesotheliomas through law were classified as occupational diseases associated 
with exposure to asbestos [51]. In a number of countries have established national cancer 
registers of mesothelioma and operate numerous government agencies and public 
associations, to examine various aspects of this pathology. The incidence of diseases caused 
by asbestos is related to fiber type, size of fibers, the dose and the industrial processing of 
asbestos [89].  
The mechanisms of carcinogenicity of asbestos may be associated with the formation in 
target organs of the active forms of oxygen, which are known to be capable of damaging cell 
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membranes, including the genetic structure of cells [91]. Under the influence of iron 
contained in large quantities in the amphibole asbestos minerals, oxygen is restored to 
superoxide with subsequent formation of hydrogen peroxide and later hydroxyl radiсal. In 
addition, the active forms of oxygen appear as a result of damage to the phagocytes by 
asbestos fibers longer than 10 µm (0. 01 mm — the so-called "long fibers") and the 
emergence of "oxidative stress" is directly into the phagocytes. ). In the literature there are 
data that the short asbestos fibers (up to 10 μm - and thickness of elementary fiber in 26 
nanometers) can directly damage the chromosomes and cell division apparatus 
(fragmentation of the chromosomes, micronuclei, mitotic spindle damage). The initial event 
in a row, leading to a malignant tumor is the emergence of cells with damaged hereditary 
structures, which is either removed from the body or remains and gives rise to a tumor. 
Recent results revealed that asbestos carcinogenesis in humans and in rodents is linked to 
the activation of the AP-1 pathway, which induces cell division, and to the secretion of TNF-
alpha (and the expression of its receptor) by mesothelial cells and by nearby macrophages 
exposed to asbestos [18]. In mesothelial cells, TNF-alpha signaling through NF-kappaB 
activation prevents apoptosis and cell death, allowing mesothelial cells to survive the 
genetic damage induced by asbestos and divide. In addition, mutagenic oxygen radicals 
released mainly by lung macrophages may contribute to asbestos carcinogenesis. Very 
recent results indicate that mineral fiber carcinogenesis can be influenced by genetics and 
microbial infections [19]. Genetic susceptibility to the mineral fiber erionite has been 
demonstrated in some Turkish families and causes a malignant mesothelioma epidemic in 
Cappadocia, Turkey. In these mesothelioma families, exposure to minimal amounts of 
erionite or asbestos appears sufficient to cause mesothelioma. Recent results demonstrate 
that SV40 and crocidolite asbestos are cocarcinogens and that, in the presence of SV40, 
significantly lower amounts of asbestos suffice to induce malignant mesothelioma [55]. 
These findings indicate that the risk varies among asbestos- and erionite-exposed 
individuals because of their genetic background or because of exposure to other 
carcinogens. Moreover, these data provide a rationale for the observation that only a 
fraction of heavily exposed asbestos workers developed mesothelioma, and novel targets for 
prevention and therapy.  
How the fibers reach the testicular area has yet to be determined, but it is understood that 
asbestos fibers can cause tumors to form in that region of the body. While there is 
currently no theory to explain why asbestos exposure might cause a primary tumor to 
develop in the testicles, it is understood that once the asbestos fibers are in the body, they 
can become lodged in organs and cause inflammation or infection that can result in the 
development of mesothelioma. The fibers cause cancerous cells to divide abnormally, 
causing build up of fluid and the development of tumors. Once cells have become 
cancerous, they are no longer able to regulate their own cycles of growth and division. A 
primary tumor that develops in the testicle is formed from cancerous cells that divide 
without restraint, which causes the thickening of the tunica vaginalis and can eventually 
lead to the formation of tumors.  
Thus, the etiology and pathogenesis of testicular mesothelioma to date until the end are 
unknown, although there are various factors that may influence for the occurrence of the 
disease, and may play a significant role to asbestos and its derivatives, and these issues 
require careful further study on the modern level.  
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5. Pathological anatomy: The macroscopic and cyto-histopathological 
features  
Serous membranes in general, and the testicular membranes, in particular, are difficult to 
built connective tissue membranes, which have a rich network of blood and lymph vessels, 
and their surface is covered by one layer of mesothelial cells - mesotheliocytes located on the 
basement membrane.  
Like any cancer testicular mesothelioma can be categorized generally into two types 
according to the type of cancerous cells. These are benign mesothelioma and malignant 
mesothelioma. The former one is a non cancerous condition while the latter is the more 
dangerous one as it spreads to other body parts. The first is the so-called adenomatoid 
tumor of genitals (mesotheliomas of sex organs), as well as fibrous mesothelioma. All other 
types of mesotheliomas, including localized in the large serous cavities are malignant.  
In International histological classification of tumors of the testis number 16, in section VII 
«"Tumors of the straight tubules, network testis, epididymis, spermatic cord, the capsule, 
supporting structures and vestigial structures" under the letters "A" and "B" are introduced 
such titles as "Adenomatoid tumor" and "Mesothelioma", respectively [48, 49]. According to 
the international histological classification of tumors of soft tissue № 3 distinguish 
predominantly epithelioid, predominantly fibrous (spindle) and a two-phase form of benign 
and malignant mesothelioma [46, 47]. In the modern classification of tumors of the urinary 
system and male reproductive organs and tumors of the lung, pleura, thymus and heart 
differentiate the: diffuse malignant mesothelioma and its types - epithelial, sarcomatoid, 
desmoplastic, biphasic (a combination of epithelial and sarcomatoid features) and localized 
(nodal) [106, 107]. It should be noted that macro-and microscopic pattern of testicular 
mesothelioma is usually no different from similar tumors of other localizations.  
Adenomatoid tumor is often benign, usually unilateral tumor of the epididymis , sometimes 
of the testicular tunica albuginea, which is about 69% of all cancers of the epididymis, but 
they can meet as malignant analogues of neoplasms [56]. Macroscopically, it is represented 
by an encapsulated, rarely plaque-like node in diameter from a few millimeters to 5 cm, 
consisting of soft or compact tissue, ivory. The tumor is usually detected in the lower pole of 
the epididymis, most of the right testicle. The histological pattern is the same everywhere. It 
does not depend on the location, but depends on the phase of the tumor development. 
Golovin [35] distinguishes the epithelial, endothelial-like, and fibromatous stage. At the 
epithelial stage the tumor is represented a conglomerate of small tubules lined by mostly a 
cuboidal epithelium. The next stage is characterized by a unique, peculiar only to the tumor, 
changes in the epithelial cells that vacuolating, flatten and become similar to endothelial (or 
mesothelial) elements. The last stage is "strangling" of the parenchymatous elements by 
growing fibrous tissue with an admixture of smooth muscle fibers, the tumor becomes a so-
called fibroma, in which only here and there is saved the remnants of the adenomatoid 
structures. The fibrous stroma may be by hyalinized, there is lymphoid infiltration. Often 
seen the smooth muscle elements, which should not be seen as a sign of invasion [34]. 
However, the confusion that reigns in the literature about its supposed histogenesis and, 
consequently, the classification provisions still exists. As potential sources of tissue called 
the endothelium, mesothelium and derivatives of mezonefron and müllerian remnants of 
moves (adenomatoid tumors in the fallopian tubes) [59]. Most of the authors believe the 
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most likely the mesothelial origin. Hence the another name - a benign mesothelioma of 
genital tract. Thus adenomatoid tumor and testicular mesothelioma, as would put on an 
equal footing, that is totally unjustified and could only lead to confusion. These two tumors 
anything among themselves do not have any clinical behaviour, histological pattern or 
histogenesis. If true mesothelioma develops in the mesothelium covering the testicular 
membranes, then adenomatoid tumor because of its epithelial nature, it is obvious in the 
early stages of development - most likely from embryonic remnants or Wolf and Müllerian 
duct. Therefore, these tumors are confused and unite under one name can not be. Testicular 
mesotheliomas grow diffusely in the form papillae, causing dropsy, the cytoplasm of tumor 
cells is not vacuolated, tumors never exposed to total fibrosis. Adenomatoid tumors 
originating from the testicular membranes, do not grow diffusely, but as a node, the 
papillary structures do not form, the dropsy do not give, their cells have characteristic large 
vacuole; tumors over time are converted into fibroma, leiomyoma rarely [35].  
Squamous cell carcinoma and adenocarcinoma in the area of testis epididymis and 
spermatic cord are extremely rare and do not have here any special clinical and 
morphological features that distinguish them from similar tumors at other sites [59].  
In addition to the adenomatoid tumor which are viewed as a derivative of the mesothelium, 
is the tumor proliferation of mesothelium benign or malignant nature, but sometimes the 
differences between the two tumors is very difficult to establish [23]. The tumor must also 
distinguish between hyperplasia, often papillary, and desquamation of the mesothelium in 
inflammatory lesions [49]. From the testicular membranes may develop benign mesothelial 
tumors. In rare instances in the testes mesothelium can be a source of papillary tumors. The 
structure of these tumors resembles that of similar tumors originating from ovarian 
membrane[34]. 
The type of benign mesothelioma is the non cancerous form of the mesothelioma and is rare 
[108]. Recently it was referred to as the "solitary fibrous tumor." It is not a cancer itself but 
can develop into cancerous forms. The benign mesotheliomа usually starts in the sub 
mesothelium layer that lies beneath the mesothelium of the testicular membranes.  
The structure of benign mesotheliomas is rather monotonous [105]. On the connective tissue 
basis with small lymphoid cell clusters are highlighted a cellular bands of the solid structure 
or in the form of tubes, closely contacting each other, anastomosing and branching. In the 
interstitial tissue are sometimes found smooth muscle fibers. Careful examination of the 
tumor proves that solid cell bands and tubular structures are a continuation of the same cell 
formations. Tumor bands are surrounded by argyrophilic frame and formed large cells with 
acidophilic cytoplasm and large round nucleus with a centrally located nucleolus. 
Sometimes the tumor bands are soft and formed a single row of cells, sometimes bands are 
wider and consist of several rows. In this case there may be gaps that have irregular shape 
and are always formed between the tumor cells in tumor bands, rather than between them 
and argyrophilic frame. These gaps include the slightly mucikarminofil liquid. The gaps 
may expand and connect with each other, and the cells on the edge of the gap are first cube, 
and then acquire the endothelial form. The cellular bands turn into tubes. Some cells are 
separated and placed in the cavity gaps. Depending on the case and the location, as well as 
in different parts of the same tumor may dominate the solid cellular bands or tubular 
formation. In the latter case, the tumor resembles and is often mistakenly regarded as a 
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lymphangioma. This similarity is enhanced by the presence in the interstitial tissue of the 
lymphoid clusters. Proof of their origin is the mesothelial brush fringe lining the cavity. A 
detailed study revealed that the apical surface of endothelial-like cells is not smooth, like 
endothelial cells, and is provided with a cuticular border and even ciliate formations. No 
similar formations in vascular endothelium and they are unique to the mesothelium. Can 
thus be considered reliable, such that tumor formation is not lymphangioma, and certainly 
not with cancer, and a benign mesothelioma. It still remains to clarify why only 
mesothelium of genital tract leads to such tumors [26, 27, 68, 69].  
Fibrous mesothelioma is a slowly growing, well-delimited node (no more than 3 cm in 
diameter) has a conical shape, the apex is directed upwards along the spermatic cord, grow 
together at the base of the epididymis, a very dense, layered on the section, whitish or light 
brownish. Only in tissue culture can prove the mesothelial origin of the tumor cells. On 
histological pattern, it has the structure of fibroma, rich in cellular elements, so it is called 
fibrous mesothelioma [26, 27, 68, 69, 96]. The structure of malignant mesothelioma in its 
main features is everywhere the same and different only in its details of macroscopic pattern 
and clinical course associated with the anatomical features of each serous cavity [13, 75]. 
Macroscopically, the tumor is in the form of a dense infiltrate, causing a dramatic thickening 
(2-3 cm, and sometimes more) of the serous membranes in a limited area or extends to the 
entire parietal and visceral sheets of the tunica vaginalis surrounding the body in the form 
of the shell, sometimes has the form of the mild delimited node from 0.5 to 6 cm oval, or 
merging several nodes with the villous surface resembling moss, destroys the epididymis 
and causes the testicular atrophy. It is white, yellow or brownish color, granular, often 
crumbles easily, in its upper part can move in the spermatic cord, and lower - in the 
epididymis [26, 27, 79]. In the thicker of infiltrates and nodes is a lot of cracks and cystic 
cavities with serous, bloody or cloudy mucus content. In the serous cavity, if it is not 
obliterated, accumulated serous or hemorrhagic exudate, often in large quantities [96]. 
Mesothelioma is prone to rapid dissemination through the lymph vessels of the serous 
membrane, resulting in the latter occurs tumor 'lymphangitis' and formed the small nodular 
lesions. Typical regional and distant metastases in lymph nodes, namely, inguinal, iliac and 
para-aortic. Hematogenous metastases is usually not excessive, but it may metastasize to the 
lungs, liver, kidneys, heart, bone, brain, thyroid, adrenal gland, skin, soft tissue. The tumor 
may grow into other body, mainly on the connective tissue interlayers with the formation in 
it of small nodules and tumor brands, but the invasive growth is not typical for 
mesothelioma, it has the exophytic growth in the thickened serous membrane. In the 
presence of a large tumor node in the body is always an assumption to metastatic lesion of 
serous membrane.  
Microscopic pattern is expressed in the appearance of papillary, solid, alveolar, glandular 
(tubular), cystic, myxomatous, fibrous, perithelial, sarcomatoid and angioma-like structures, 
which in some cases may dominate [74, 80, 101, 115]. All this creates considerable 
polymorphism of the microstructure of the tumor [96]. The types of malignant tumor or 
cancer cells involved in the development of mesothelioma are of three main types namely 
epithelioid, sarcomatoid and mixed or biphasic cells [46, 106]. Among the most frequent 
histological variants of mesothelioma is epithelioid (50-70%) as a set of buds with delicate 
gripping growths covered with prismatic, cubic or polygonal cells with pale vacuolated 
cytoplasm and with evidence of cellular polymorphism, hyperchromatosis of the nuclei, the 
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presence of pathological mitoses and giant cells, as if spun from each other, that is, in our 
opinion, the pathognomonic morphological sign of mesothelioma, and for which can not be 
wrong [115]. The other type is sarcomatoid which is much more serious than the epithelioid, 
and it affects the secondary tissues including the bone, muscles, cartilage or fat [94]. This 
type of cancer cell is a much more rare type that occurs in 7-20% of the cases. Mixed 
(biphasic) refers to both types of cancers that occurs simultaneously, and making up the rest 
of the 20-35% of the mesothelioma cases that are reported. A feature of the tumor is large 
variety of morphological structure, as well as the ability to form structures characteristic of 
both epithelial and connective tissue for growth. Connective tissue differentiation is less 
common than epithelial. It is expressed in the transformation of mesothelial cells into 
elongated elements, such as fibroblasts, which are formed into bundles, severed in various 
directions. Between the tumor cells are elongated in one way or another including 
argyrophilic and collagenous fibers. Tumor cells were clearly involved in their formation. 
These special morphogenetic potency are disclosed already in conditions of inflammation 
and tissue culture [26, 27]. Histological structure of the epithelial type of mesothelioma is 
typical enough: they are not similar to any other epithelial tumors and are recognized easily 
[76]. Connective tissue options is more difficult to distinguish from fibrosarcoma. And they 
both consist of elongated cells that produce collagen fibers. But fibrosarcomas are small-
spindle-cells tumors and relatively rich in mitoses, whereas fibroblasts of mesothelial origin 
differ by polymorphism and this polymorphism in a strange way contrasts with the paucity 
of mitoses. In general, cells of all types of mesotheliomas is rarely share by mitosis and is a 
valuable diagnostic feature.  
In the study of tumors of this region has to overcome some difficulties to determine their 
exact location. Of course, when the tumor is small and not adherent to surrounding tissues, 
then we can easily establish that it is within the epididymis, spermatic cord, or testicular 
membranes. But often fall into the hands of a pathologist large tumors that were released 
outside the body in which they are evolved, and spliced to the surrounding tissues. In such 
cases, the localization can be expected speak only. This circumstance creates a condition 
where in each case it would be better to speak in favour of mesothelioma of paratesticular 
zone, but without precise localization. However, I would like to focus on those cases where 
the tumor location is beyond doubt.  
According to Klimanova [54], the cellular composition of the exudate with mesothelioma in 
each case differs significantly by originality, but on aggregate the most of common 
cytomorphological features all cytograms can be summarized in three main groups. When 
cytograms having a picture of glandular cancer, tumor cell elements are arranged as a 
circular complexes, rosettes, and glandular-like and papilla-like structures, clusters and 
isolated. According to the degree of polymorphism and anaplasia of tumor cells in each case 
the cytograms are somewhat different. However, as a rule, the cell structure consists mainly 
of rounded cells, there are cubic and prismatic cells. Sometimes there is a sharply 
pronounced nuclear and cellular polymorphism, in the cytoplasm along with the large cells 
are small and giant cells, the latter are often multinucleated. Cell nuclei predominantly 
round and oval, of different sizes, coarse-grained chromatin pattern or small-grained, 
sometimes thin with non-uniform illumination. Sharply hypertrophied nucleoli are seen in 
the nuclei. With a low differentiation of cellular elements the cytogram looks more 
monomorphic, since the basic number of elements are rounded cells of medium size with a 
narrow zone of basophilic cytoplasm.  
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Among cytograms of mesothelioma, like cytograms for regenerative proliferative processes, 
can be identified two types. When one of these cellular elements are very similar to the 
lining of a serous cover under physiological conditions, and only the abundance of them in 
the exudate indicates a pathology. The cells are arranged as a vast, one-layer clusters, bands, 
and layers, are enlarged to the round, polygonal and elongated shape. Signs of atypia of the 
cellular elements are expressed mild. However, there are discomplexation of nuclei, their 
polymorphism, the uneven pattern of chromatin (granular or small-grained with broad 
achromatic zones). The hypertrophied nucleoli are visible in the nuclei. In part of the nuclei 
with large size have revealed signs of severe dystrophy. In the second form of mesothelioma 
cells cytograms by location is very similar to the elements of a well differentiated glandular 
cancer or of proliferating mesothelium. They are mostly round-shaped, medium sized, form 
a round, or similar to the papillae complexes, glandular-like structure, rows and clusters of 
other shapes. Enlarged cell nuclei are located centrally and eccentrically, the cytoplasm is 
colored differently intensively, smile-grained or fine-vacuolated.  
In cytograms of mixed type are present both epithelial and connective tissue cells. Epithelial 
cells are arranged in the form of the layers, papilla-like, glandular-like structures, and 
clusters and isolated. They are the same type, mostly rounded, sometimes cubic, vary 
considerably in size. Cell nuclei are rounded or oval shape of various sizes, located centrally 
or eccentrically. The structure of chromatin in some nuclei are uniformly grained, in other 
small-grained. Many nuclei are hyperchromatic, some of them contain the hypertrophied 
nucleoli. The cytoplasm surrounds the nucleus in a narrow or wide rim, is stained unevenly. 
In some cells more intensely it is stained in the center around of the nucleus, the other 
reveals a bright ring in the middle of the cytoplasm. There are cells with the morphological 
characteristics of secretion (the signet ring cell is a cell type with a narrow intensively 
stained rim of the cytoplasm, which surrounds the vacuole filled with grainy masses of 
secretion). The cells form of connective tissue similar to the fibroblasts or fibrocytes, are 
arranged in bundles, bands, clusters and isolated. They are small in size, of the spindle or 
elongated shape, often with spines of different lengths. The cell nuclei are of round and oval 
shape, average sizes, sometimes large. Many nuclei are hyperchromatic stained, with 
irregular contours and uneven chromatin pattern. The cytoplasm of most cells are stained 
weakly basophilic, granular or has bands. Both types of cellular elements (epithelial and 
connective tissue) as is mixed in cytogram and often formed intimately the interrelated 
clusters. Сytologic differential diagnosis of mesothelioma in exudate is very difficult Most 
often, the cytogram has a pattern of the glandular cancer. Suspected mesothelioma, in this 
case can only be a careful examination of the entire cellular composition, when I find an 
abundance of cells and different cell groups, characteristic of epithelial tumors, some types 
of connective tissue cells and structural formation of them. It should be noted that the 
mesothelioma even with sharply expressed atypia cells has elements similar to proliferating 
or dystrophic mesothelium. Especially valuable if all three types of cellular elements 
(specific to cancer, similar to the mesothelium and the connective tissue nature) are in close 
contact, and often in direct connection. In the absence of pronounced signs of mesothelioma 
cells atypia have many similarities with their mesothelium in able of regenerative 
proliferation, diagnosis can be made only when taken into account the clinical data for this 
disease.  
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Cytological diagnosis of mesothelioma is set in the mixed cellular composition of cytograms 
if, in addition to the cells and structures of the epithelial type observed a large number of 
fibroblastic cells type and structures with the nature of the connective tissue growth.  
Thus, in accordance with the macroscopic, histological and cytological study of tumor 
substrate of paratesticular zone are released the benign and malignant mesotheliomas, cyto-
histological pattern which it is extremely polymorphic and not always pathologists, 
experiencing the considerable difficulties, can reliably determine their precise localization, 
namely, the testicular membranes, spermatic cord or its epididymis.  
6. Clinical data: Signs and symptoms 
Clinical picture is made up of symptoms caused by the presence of the primary 
paratesticular tumor and its metastases, or a combination thereof [92]. Mesothelioma 
originating from the serous membranes of the testis, epididymis or its spermatic cord, 
accompanied by increased and in most cases combined with a hydrocele [28, 83, 100]. 
Initially the testicular tumor is asymptomatic. The speed of its development is uncertain. 
However, most often asymptomatic tumor growth lasts no more than 1-2 months. The most 
frequent symptoms of primary paratesticular tumor are pain, increasing in size or swelling 
of the body with the appearance of palpable tumor in their formation. With the growth of 
tumor the testis increases, it becomes dense, lumpy due to the appearance of testicular 
lumps, which are pathognomonic diagnostic symptom of testicular mesothelioma, and later 
joins the adhesion process associated with the skin of scrotum [57, 95]. The increase of the 
testis as the main and only symptom noted in 54% of patients. The pain is the result of a 
significant increase of intratesticular pressure, germination of the tunica vaginalis of testis or 
elements of the spermatic cord and is often a sign of far-gone of the disease. Acute pain in 
the testicle and his the increasing simulate the clinical picture of acute epididimoorhit, the 
accession of hydrocele in 10% of the cases is typical for tumor lesion. The pain may radiate 
to the groin, thigh and lower back before the emergence of metastases. In 5% of cases the 
only symptom may be pain in the back. Often the symptoms associated with the presence of 
metastases predominate over local symptoms of the testicular lesion. Thus, severe pain in 
the back may indicate to an increase in the retroperitoneal lymph nodes, which squeeze the 
nerve rootlets, or to the involvement in the process of the psoas muscle. Often there are 
gastrointestinal symptoms (nausea or vomiting, diarrhea, abdominal pain), loss of weight, 
fatigue, muscle weakness, and sometimes in the abdominal cavity on palpation is revealed a 
tumor. The spread of the tumor above the diaphragm can lead to the discovery in the left 
supraclavicular area of the visible tumor masses and to the complaints of shortness of 
breath, chest pain, cough, hoarseness, and heart palpitations.  
7. Diagnosis and differential diagnosis 
The rarity of the testicular mesothelioma makes it extremely difficult to diagnose [61].The 
primary malignant neoplasm of the testis serous membranes, its epididymis and the 
spermatic cord is very difficult for intravital diagnosis, not only in earlier, but in the later 
stages of the disease. In addition, the diagnosis of mesothelioma is imperfect, usually 
heavily delayed and it is no accident that this tumor remains an enigma for the oncologist 
[53]. The cancer typically progresses to the later developmental stages before the patients 
learned of their diagnosis in the documented cases of the testicular mesothelioma.  
www.intechopen.com
Mesotheliomas – Synonyms and Definition, Epidemiology, Etiology,  
Pathogenesis, Cyto-Histopathological Features, Clinic, Diagnosis, Treatment, Prognosis 
 
60
Its an accurate diagnosis is obtained at best from pathologic study of resected tumor and at 
worst from postmortem examination [114]. A combination of clinical, X-ray, laboratory, and 
instrumental techniques is used to make the diagnosis. The diagnosis should be based 
primarily on the exclusion of the primary tumor in various internal organs, and first of all, 
lung, stomach, pancreas, gall bladder and others. The diagnosis is based on precise 
localization of the tumor and the availability in it of ciliated epithelial cells (primitive cells of 
the coelom), while using the testicle self-examination can be established an early diagnosis 
of the testicular cancer. Be that as it may be, any tumor in the testis should be considered as 
a possible his cancer, and every patient with suspected to a malignant tumor of the testicular 
region should be examined promptly by a surgeon-urologist, or oncologist. Diagnosis is 
made up of data history, physical examination, palpation, laboratory tests, radionuclide 
diagnostics, ultrasound, positron emission tomography, remote infrared thermography, 
magnetic resonance imaging for detection of metastases and a biopsy [39]. The palpation 
study is the first diagnosis stage of testicular mesothelioma. With continued examination the 
doctor should carefully to investigate the status of inguinal, abdominal, supraclavicular, and 
other lymph nodes accessible to research, to draw an attention to the breasts to detect a 
possible gynecomastia. Transillumination, which allows to distinguish a tumor that does not 
transmit light from a cyst filled with fluid, refers to an affordable and highly informative 
survey techniques [3]. In all patients with suspected to the testicular malignant tumor is 
necessary to conduct an ultrasound of the scrotum [70]. An ultrasound is a noninvasive and 
relatively inexpensive method, and accuracy of study in testicular tumors is very high and 
reaches 90% [14, 25]. Testicle ultrasound is used for differential diagnosis of testicular 
tumors and other diseases, such as epididymitis. However, basing a diagnosis solely on 
ultrasound imaging can not, because based on the results of the study can not clearly 
differentiate tumor from inflammation. Magnetic resonance imaging is more accurate 
method, but because of the high cost is not always used in routine practice. Nevertheless, in 
some observations the magnetic resonance imaging should be used to resolve disagreements 
arising between the ultrasound and physical examination [6]. Cytological examination of the 
tumor punctate has supporters and opponents. The puncture of the tumor is a danger of its 
dissemination. In addition, the puncture biopsy does not give the full picture of the 
morphological features of the tumor, but negative cytology does not exclude the existence of 
neoplasms. However, in recent years strengthened the view that the puncture in suspected 
testicular tumor is very valuable, simple and harmless study [1, 52]. Hydropic fluid from the 
testicular membranes should be subjected to compulsory cytology. Radiacal orchiectomy 
with subsequent histological examination of obtained material allows to diagnose a 
testicular tumor. 
After identifying of the primary tumor is necessary to determine the stage of disease in the 
light of the lesion of lymph nodes and presence of distant metastases [73]. Computed 
tomography is the most accurate method of determining the lesion of the lymph nodes, 
mainly retroperitoneal. However, be aware that 25-30% of patients with testicular tumor 
and the absence of data computed tomography showing the lesion of the lymph nodes, and 
morphological study revealed the microscopic metastases in the last. Other frequently used 
methods of diagnosis of retroperitoneal lymph node metastases are cavography and 
lymphangiography. With a significant increase of retroperitoneal lymph nodes in the 
excretory urogram is possible to detect a displacement or compression of the ureter. The 
lungs are the most frequent localization of distant metastases of testicular tumor. To identify 
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them it is need perform not only lung X-rays in two projections, but also computed 
tomography of the chest, allowing to detect metastases in diameter up to 3 mm [26]. 
Metastatic liver lesions can be detected by ultrasound and scintigraphy of the liver, and the 
presence of metastases in the brain of an informative role in the diagnosis is given of 
magnetic resonance imaging. Experts are reserved to the primary tumor biopsy, and with 
great enthusiasm to the removal of metastases for histological examination. So much activity 
can be explained by three reasons. First, the biopsy helps to determine the extent of 
distribution of the tumor process. Secondly, if you delete metastasis, in addition to 
histological examination, it is possible that he was single and, of course, the procedure 
would be of great benefit to the patient. Third, the histological study of metastasis, despite 
the fact that there is a conclusion of the primary tumor, can make a change in the 
morphological verification of diagnosis, and consequently in the nature of the treatment. 
The task of staging process is to determine the prevalence and nature of both the primary 
tumor and its metastases. The level of serum markers of human chorionic ǃ-gonadotropin, 
ǂ-fetoprotein and lactate dehydrogenase to be determined in pre-and postoperative period, 
and in the future - with weekly intervals. The situation in which after the operation the level 
of ǂ-fetoprotein and human chorionic ǃ-gonadotropin is not normal, indicates the 
prevalence of the disease, which makes justified those serological tests. In this case, shortly 
after radical orhiectomy should be performed computed tomography (an advantage of 
magnetic resonance imaging has not yet proved) of the chest, abdomen and pelvis. When 
using classification by the TNM system is required histological confirmation of the diagnosis 
[8]. Histological verification of both mature and immature mesotheliomas is very difficult. 
Histogenesis and morphology of testicular tumors can be reliably determined only by 
histotopographical, and sometimes even serial sections. Therefore, the best way to 
determine the diagnosis is to obtain a tissue sample from the area. The sample may then be 
biopsied and examined for the presence of cancerous cells. Once a diagnosis is confirmed, 
the patient will be referred to an oncologist to determine a course of treatment.  
Differential diagnosis between mesothelioma and their simulating metastatic tumors is 
based on the combined of anatomical, histological and clinical data. On the basis of a 
microscopic examination of mesothelioma from adenocarcinoma is difficult to differentiate 
[2]. In the analysis of the microstructure is of great importance to the presence of 
polymorphism of the tumor areas resembling to the angioendotheliomа, spindle-
polymorphocellular sarcoma, etc., which is not characteristic of cancerous tumors. The 
structure of mesothelioma is also unlike to any the testicular disgerminoma. The latter has a 
pronounced solid-alveolar structure, and is too small glandular differentiation, to assume 
that it occurs in the epididymis or testicular tubules [26].  
Recently, using different immunohistochemical markers for mesotheliomas, in particular, 
they are positive for cytokeratin, cytokeratin 7, Ǆ-glutamylcysteine synthetase, vimentin, 
mesothelin, epithelial membrane antigen, thrombomodulin, calretinin, and mesothelial 
antibody, whereas mesotheliomas are negative for cytokeratin 20 and carcinoembryonic 
antigen [24, 50, 65, 112]. However, it is not always and not all the conventional tumor 
markers allow you to make a diagnosis [16, 97]. For example, the carcinoembryonic antigen, 
usually is determined at low concentrations, whereas, the tissue polypeptide specific 
antigen and the cytokeratin fragment 21-1 are identified only occasionally in high 
concentrations. Differential diagnosis of testicular tumor have to spend with specific and 
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nonspecific inflammatory diseases of the testis, as well as with a hydrocele, hematocele, 
hematoma, hernia, and testicular torsion [66]. Tuberculous orchitis is confirmed by the 
tuberculous lesion of kidney, prostate, seminal vesicles. The gender history and 
Wasserman'reaction have an important role in cases of suspected syphilis in the testis. If you 
suspect a diagnosis of brucellosis orchitis is specified by the agglutination test, at Wright-
Haddlson, complement fixation reaction with allergic intracutaneous test. In doubtful cases, 
for the differential diagnosis of chronic orchitis and testicular tumor is shown holding of an 
emergency open biopsy on the operating table. Accurate diagnosis can be made using the 
immunohistochemical typing with the use of monoclonal antibodies, as well as the method 
of tissue culture.  
Thus, the difficulty of the diagnostic process in the diagnosis of testicular mesothelioma is 
obvious. Therefore, a breakthrough in improving its diagnosis should be sought in the 
widespread institutional arrangements, consisting in close collaboration of the various 
medical specialties in specialized medical centers a qualitatively of new level.  
8. Treatment  
Over the past two decades in the treatment of testicular cancer has been quite remarkable, 
resulting in 5-year survival rate in the U.S. and Europe has reached 90-95% [3, 31]. However, 
in many countries rates of 5-year survival rate is much lower. In Russia (St. Petersburg), 5-
year survival rate for patients with testicular cancer is 73%. In the treatment of testicular 
mesothelioma distinguish 3 main methods: 1) the operation, 2) radiation therapy, and 3) 
chemotherapy. Often, depending on the tumor stage is used combined (multimodal) 
treatment with two or all three methods, which is recommended, particularly, for the 
treatment of diffuse mesothelioma [109]. Approaches to treatment are being developed for 
neoadjuvant therapy with cytokines only in the early stages. Operation is possible only in 
the early stages of the disease [102]. Treatment is surgical of adenomatoid tumors, usually 
with a good prognosis. Radiation therapy is used mainly with palliative purpose. Radiation 
may be used if the patient's health cannot withstand a major operation. The treatment of the 
testicular tumors depends on several factors including the histological structure of the 
tumor, stage of disease, the presence of contralateral testicular damage and general state of 
the patient and his opinion. The main problem is the timeliness of treatment and the 
sequence of preoperative radiation execution, the remove of the primary tumor, the 
diagnostic and therapeutic lymphadenectomy and the chemotherapy effects in the cancer 
institutions [21, 98]. Malignant mesothelioma is difficult to treat, because it is not a 
centralized tumor mass [72]. Mesothelioma tends to spread along nerves, blood vessels, and 
surfaces. Because of this tendency to spread, multiple methods of treatment must be 
employed to fight the cancer, and treatment is often unsuccessful if the cancer is in a later 
stage.  
The most common treatment option available for testicular mesothelioma is the removal of 
the testicles, or a portion of it [40]. If the cancer has advanced very high, it may be necessary 
to remove the entire testicles. Surgery can be performed to remove the cancer in addition to 
radiation and chemotherapy. These methods are usually used to relieve symptoms related 
to mesothelioma. Other treatment options available are сhemotherapy or radiation therapy 
[41]. Chemotherapy or radiation may also be suggested following surgery to kill any 
cancerous cells that may remain. Radiation therapy will attempt to kill any cancerous cells 
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in the testicles via the help of a high beam razor that directly targets tumorous cells. As the 
successful schemes used chemotherapy for tumors of the testis recommend complex, 
involving the use of cisplatin, mitomycin, vinblastine, etoposide, doxorubicin, bleomycin, 
gemcitabine, and folic acid, which in combination are effective in 90% of cases [64].  
If malignant mesothelioma is diagnosed in stage I of the disease, surgery is often used to 
remove tumor masses. If mesothelioma is diagnosed during the initial stage, surgery will 
usually be performed to remove the tumor. The use of chemotherapy and radiation after 
surgery is still being studied to determine a good course of action for mesothelioma 
treatment. In stages II and III, symptom relief is stressed because mesothelioma is often 
incurable at this level of development of the cancer. Surgery to remove as much of the 
cancer as possible is employed, as well as some chemotherapy and radiation. In stage IV, 
malignant mesothelioma spreads to organs distant from the original site of disease and 
becomes impossible to cure. A hospice or supportive care is usually the best option for this 
advanced form. The patient may also wish to try alternative methods of therapy for pain 
relief, including acupuncture. In addition, testicular mesothelioma tends to recur within a 
few years, even in cases where tumors are surgically removed [58]. It is also necessary to 
remember that 1-3% of patients with testicular cancer is the risk of cancer in the other 
testicle. Therefore, it is necessary to improve methods of treatment to reduce the frequency 
of relapses and worsening prognosis [88]. In this sense, periodic surveillance and screening 
are important in patients with testicular cancer. With a view to early detection of tumor 
recurrence must regularly determine the levels of tumor markers such as alpha-fetoprotein, 
human chorionic ǃ-gonadotropin and lactate dehydrogenase. Moreover, it should be 
regularly assigned to X-rays of the chest and the appropriate methods of radiological 
investigations to detect recurrence, metastases or occurrence of multiple primary tumors.  
It is always necessary to remember that in the course of treatment for testicular 
mesothelioma or after may occur the following complications [25]:  
1. Practically in all patients with radio-and chemotherapy leads to oligospermia. Many 
observations of spermatogenesis recovered in 1-2 years and 2 years after chemotherapy 
with one testicle preserved the ability to fertilize are generally returned.  
2. Chemo-and radiotherapy increase the risk of secondary leukemias. The greatest risk of 
leukemia (0.5% in 5 years) has been established for patients receiving etoposide.  
3. Nephrotoxicity. During chemotherapy with platinum drugs may be a slight decrease in 
creatinine clearance - on average by 15%.  
4. Ototoxicity. Decreases mainly the perception of sounds with a frequency of 4.8 kHz, ie 
not spoken frequency.  
5. Retrograde ejaculation. Occurs as a complication of retroperitoneal lymphadenectomy 
due to standard intraoperative intersection of sympathetic pathways, providing a reflex 
contraction of the bladder neck during ejaculation.  
6. The development of secondary tumors. Established higher incidence of stomach cancer, 
bladder and pancreas. 
Thus, treatment in testicular tumors developed in some detail, but research in this area are 
continuing. The main areas of focus are to develop the optimal treatment strategy of 
residual retroperitoneal tumors after chemo- or radiation therapy, treatment of patients with 
bilateral tumors and cancer of the single testis, more efficient treatment of chemoresistant 
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cancer. Given the rarity of the disease, it is advisable to carry out the treatment in the 
specialized cancer institutions that have experience in treating such patients. For each 
method of treatment are possible complications that may persist for several months. 
Knowledge of therapy complications may help to fight them. Currently, there is intensive 
development of promising new methods of treatments, like gene therapy, photodynamic 
therapy and immunotherapy, which are the subject of clinical studies and that really can 
qualitatively change the suffering of the patients with testicular mesothelioma in the near 
future.  
9. Prognosis 
Testicular malignant mesothelioma is considered to be a very clinically aggressive form of 
cancer, spreading quickly [86, 103]. Because of this, the prognosis for a patient with this 
form of mesothelioma is often poor [73, 93]. However, the prognosis depends on factors 
such as age, macro-microscopic version, stage of disease, intercurrent illness. Severe 
intercurrent diseases, stage 3 and 4, diffuse form and sarcomatoid or biphasic types of 
testicular mesothelioma and advanced age are associated with a poor prognosis [38]. The 
median survival after diagnosis of testicular mesothelioma is 1 year and five-year survival is 
10%. Most patients die within 2 years after their diagnosis. In the U.S., a 5-year survival rate 
for mesothelioma patients is 28%. In Russia the figure is 23%. Out of all types of testicular 
cancers, the survival rate after ten years is around 98%.  
Thus, the prognosis for testicular mesothelioma in the light of certain factors set forth above 
are generally unfavorable, and the determination of histological variants of tumors has 
important prognostic value in relation to anything other than light microscopy in the 
diagnosis of mesothelioma are commonly used methods of immunohistochemistry and 
electron microscopy. 
10. Conclusion 
From this analytical review of the world literature implies that the testicular mesothelioma 
is a mysterious and rare tumor originating from mesotheliocytes, covering the serous 
membranes of the testis, epididymis and spermatic cord with an unknown etiology and 
pathogenesis, a poor clinic and prognosis, and as a rule, of the late diagnosis, in spite of 
intensive development and application of new methods of diagnosis and treatment in recent 
years. The speed of the correct diagnosis establishing, prevention and treatment of the 
testicular mesothelioma depend on the attention to the health of the patient's cancer, 
oncological vigilance and art of a doctor, from the provision of modern medical equipment, 
from a qualitative immunohistochemical, immunophenotypical and cytogenetic studies 
with the use of modern medical and computer technologies and techniques, as well as on 
the creation in all highly developed countries of the united, up-to-date, organizational, 
methodical, consultative, and statistical centres on studying human pathology at a 
qualitatively new level – the national centres of pathology, in which multiple studies on the 
etiology, patho-and morphogenesis of tumors, and in particular, mesothelioma testis, and 
also analysis of the intravital diagnosis of the character of pathological processes according 
to data of cytologic, biopsy and autopsy banks with the help of modern computer and 
telecommunication technologies would be carried out. 
www.intechopen.com
 
Testicular Mesothelioma 
 
65 
11. References 
[1] Ahmed M, Chari R, Mufi GR, Azzopardi A. Malignant mesothelioma of the tunica 
vaginalis testis diagnosed by aspiration cytology – A case report with review 
literature. Int Urol Nephrol 1996; 28 (6): 793–796.  
[2] Akyildiz EU, Oz B., Schitoglu I, Demir H. The diagnostic utility of maspin in the 
distinction between malignant mesothelioma and pulmonary adenocarcinoma. J Int 
Med Res 2010; 38 (3): 1070–1076. 
[3] Alexandrov VP, Mikhailichenko VV. Urology and andrology. The modern guide for 
physicians. In: Diseases and injuries of the scrotum. Chapter 12; 414–440. Moscow: 
“AST”; St. Petersburg: “Sova” 2005; 576 p (in Russian).  
[4] Al-Qahtani M, Morris B, Dawood S, Okerheim R. Malignant mesothelioma of the tunica 
vaginalis. Can J Urol 2007; 14 (2): 3514–3517.  
[5] Al-Shukri SKh, Tkachuk VN. Tumors of the genitourinary organs. Guide for physicians. 
In: Testicular tumors. Chapter 8; 159–181; Tumors of the testicular epididymis. 
Chapter 9; 182–183; Tumors of the spermatic cord. Chapter 10; 184–187. St. 
Petersburg: “Piter” 2000; 320 p (in Russian).  
[6] Andipa E, Liberopoulos K, Asvestis C. Magnetic resonance imaging and ultrasound 
evaluation of penile and testicular masses. World J Urol 2004; 22: 382–391.  
[7] Attanoos RL, Gibbs AR. Primary malignant gonadal mesotheliomas and asbestos. 
Histopathology 2000; 37: 150–159.  
[8] Avtandilov GG. Fundamentals of pathoanatomical practice. Leadership. Moscow: 
“RMAPO” 1994; 512 p (in Russian).  
[9] Benchekroun A, Jira H, Ghadouane M, Kasmaoui EH, Marzouk M, Faik M. 
Paratesticular malignant mesothelioma. Report of a new case. Ann Urol (Paris) 
2001; 35 (5): 293–295.  
[10] Bianchi C, Brollo A, Ramani L and Bianchi T. Malignant mesothelioma in Europe. Int J 
Med Biol Environ 2000; 28 (2): 103–107.  
[11] Bianchi C, Brollo A, Ramani L and Bianchi T. Malignant mesothelioma in Central and 
Eastern Europe. Acta med Croat 2000; 53 (4–5): 161–164. 
[12] Bianchi C, Bianchi T. Amianto un secolo di sperimentazione sull’uomo. Trieste: 
Hammerle Editori 2002; 102 p.  
[13]  Bisceglia M, Dor DB, Carosi I, Vairo M, Pasquinelli G. Paratesticular mesothelioma. Report 
of a case with comprehensive review of literature. Adv Anat Pathol 2010; 17: 53–70. 
[14] Blaivas M, Brannam L. Testicular ultrasound. Emerg Med Clin North Amer 2004; 22: 
723–748. 
[15] Butnor KJ, Sporn TA, Hammnar SP, Roggli VL. Well-differentiated papillary 
mesothelioma. Am J Surg Pathol 2001; 25: 1304–1309.  
[16] Cabay RJ, Siddiqui NH, Alam Sh. Paratesticular papillary mesothelioma: A case with 
borderline features. Arch Pathol Lab Med 2006; 130 (1): 90–92.  
[17] Carbone M. Simian virus 40 and human tumors: It is time to study mechanisms. J Cell 
Biochem 1999; 76 (2): 189–193.  
[18] Carbone M, Barbanti-Brodano G. Viral Carcinogenesis. Chapter 17; 214–232. In: Section Two. 
Translational Basic Science / Oncology. An Evidence-Based Approach Edited by Alfred 
E Chang, Patricia A Ganz, Daniel F Hayes, Timothy J Kinsellla, Harvey I Pass, Joan H 
Schiller, Richard M Stone, Victor J Strecher. New York: Springer 2006; 2022 p.  
[19] Carbone M, Bedrossian CW. The pathogenesis of mesothelioma. Semin Diagn Pathol 
2006; 23 (1): 56–60.  
www.intechopen.com
Mesotheliomas – Synonyms and Definition, Epidemiology, Etiology,  
Pathogenesis, Cyto-Histopathological Features, Clinic, Diagnosis, Treatment, Prognosis 
 
66
[20] Carbone M, Fisher S, Powers A, Pass HI, Rizzo P. New molecular and epidemiological 
issues in mesothelioma: Role of SV 40. J Cell Physiol 1999; 180(2): 167–172. 
[21] Castillo OA, Alvarez JM, Vitagliano G, Ramirez D, Diaz M, Sanchez-Salas R. 
Limfadenectomia retroperitoneal laparoscopia en cancer de testiculo no seminoma 
estadio. Arch esp urol 2007; 60 (1): 59–66.  
[22] Churg A. Chrysolite, trenolite, and malignant mesothelioma in man. Chest 1988; 93 (3): 
621–628.  
[23] Churg A, Colby TV, Cagle P, et al. The separation of benign and malignant mesothelial 
proliferations. Am J Surg Pathol. 2000; 24: 1183-2000.  
[24] Ekman S, Eriksson P, Bergstrom S, Johansson P, Goike H, Gulleo J, Henriksson R, Larsson 
A, Berqovist M. Clinical value of using serological cytokeratins as therapeutic 
markers in thoracic malignancies. Anticancer Res 2007; 27 (5B): 3545–3554.  
[25] Fedorov VD, Pikunov MYu, Shchegolev AI, Dubova EA, Kamalov AA, Nikushina AA. 
Tumors of testicle. Khirurgiya. Zhurnal imeni NI Pirogova 2007; (5): 68–74 (in Russian).  
[26] Foot N. Identification of Tumors. Philadelphia, London, Montreal: J.B.Lippincott Co 
1948; 397 p. 
[27] Foot N. Identification of Tumors. Translated from English V.B.Freiman / Prof. 
Ya.L.Rapoport (Ed). Moscow: Foreign Literature Publishing House 1951; P.41–42; 
P.140 (in Russian).  
[28] Fujii Y, Masuda M, Hirokawa M, Matsushita K, Asakura S. A case of benign 
mesothelioma of the tunica vaginalis testis. Hinyokika Kiyo 1993; 39 (1); 89–92.  
[29] García de Jalón A, Gil P, Azúa-Romeo J, Borque A, Sancho C, Rioja LA. Malignant 
mesothelioma of the tunica vaginalis. Report of a case without risk factors and 
review of the literature. Int Urol Nephrol 2003; 35: 59–62. 
[30] Gibbs GW, Berry G. Mesothelioma and asbestos. Regul Toxicol Pharmacol 2008; 52: 
S223–31.  
[31] Gilligan T, Kantoff PW. Testis Cancer. Chapter 49; 844–873. In: Section Five. Solid 
Tumors / Oncology. An Evidence-Based Approach Edited by Alfred E Chang, 
Patricia A Ganz, Daniel F Hayes, Timothy J Kinsellla, Harvey I Pass, Joan H 
Schiller, Richard M Stone, Victor J Strecher. New York: Springer 2006; 2022 p.  
[32] Goel A, Agrawal A, Gupta R, Hari S, Dey AB. Malignant mesothelioma of the tunica 
vaginalis of the testis without exposure to asbestos. Cases J 2008; 1:310. 
[33] Goldberg S, Rey G, Luce D, Ilg AGS, Rolland P, Brochard P, Imbernon E, Goldberg M. 
Possible effect of environmental exposure to asbestos on geographical variation in 
mesothelioma rates. Occup Environ Med 2010; 67 (6): 417–421.  
[34] Golovin DI. Atlas of human tumours. Leningrad: Publishing House "Meditsina" 1975; 
P.201–205 ; P.306–309 (in Russian).  
[35] Golovin DI. Errors and difficulties in histological diagnosis of tumors: (a guide for 
physicians). Leningrad: «Meditsina» 1982; 304 p (in Russian). 
[36] Gorini G, Pinelli M, Sforza V, Simi U, Rinnovati A, Zocchi G. Mesothelioma of the 
tunica vaginalis testis: reported of 2 cases with asbestos occupational exposure. Int J 
Surg Pathol 2005; 13 (2): 211–214. 
[37] Grove A, Jensen ML, Donna A. Mesotheliomas of the tunica vaginalis testis and hernial 
sacs. Virchows Archiv 1989; 415: 283–292.  
[38] Guney N, Basaran M, Karayigit E, Muslumanoglu A, Guney S, Kilicaslan I, Gulbarut S. 
Malignant mesothelioma of the tunica vaginalis testis: a case report and review of 
the literature. Med Oncol 2007; 24 (4): 449–452.  
www.intechopen.com
 
Testicular Mesothelioma 
 
67 
[39] Gupta NP, Agrawal AK, Sood S, Hemal AK, Nair M. Malignant mesothelioma of the 
tunica vaginalis testis: a report of two cases and review of literature. J Surg Oncol 
1999; 70: 251-254.  
[40] Gupta NP, Kumar R. Malignant gonadal mesothelioma. Curr Treat Opt Oncol 2002; 3 
(5): 363–367. 
[41] Hamm M, Rupp C, Rottger P, Rathert P. Malignant mesothelioma of the tunica 
vaginalis testis. Chirurg 1999; 70 (3): 302–305.  
[42] Hassan R, Alexander R. Nonpleural mesotheliomas: mesothelioma of the peritoneum, 
tunica vaginalis, and pericardium. Hematol Oncol Clin North Am. 2005; 19: 1067–1087. 
[43] Hatzinger M, Hacker A, Langbein S, Grobholz R, Alken P. Malignant mesothelioma of 
the testes. Aktualle Urol 2006; 37 (4): 281–283.  
[44] Hodgson JT, McElvenny DM, Darnton AJ, Price MJ, Peto J. The expected burden of 
mesothelioma mortality in Great Britain from 2002 to 2050. Br J Cancer 2005; 92: 587–593. 
[45]  Hyland RA, Ware S, Johnson AR, Yates DH. Incidence trends and gender differences in 
malignant mesothelioma in New South Wales, Australia. Scand J Work Environ 
Health 2007; 33 (4): 286–292. 
[46]  International Histological Classification of Tumours N 3. Histological Typing of Soft 
Tissue Tumours / FM Enzinger, R Lattes, H Torloni (Eds). World Health 
Organization. Geneva, 1969. 
[47] International Histological Classification of Tumors N 3. Histological Typing of Soft 
Tissue Tumors / FM Enzinger, R Lattes, H Torloni (Eds). World Health 
Organization. Geneva, 1974; P.23–24 (in Russian).  
[48] International Histological Classification of Tumours N 16. Histological Typing of Testis 
Tumours / FK Mostofi, LH Sobin, et al (Eds). World Health Organization. Geneva, 1977. 
[49]  International Histological Classification of Tumours N 16. Histological Typing of Testis 
Tumours / FK Mostofi, LH Sobin, et al (Eds). World Health Organization. Geneva, 
1981; P.16; P.36 (in Russian).  
[50] Jones MA, Young RH, Scully RE. Malignant mesothelioma of the tunica vaginalis. A 
clinicopathologic analysis of 11 cases with review of the literature. Am J Surg 
Pathol 1995; 19: 815-825. 
[51] Kashansky SV. Mesothelioma in Russia: systematic review of 3576 published cases from 
occupational medicine viewpoint. Occupational medicine and industrial ecology 
2008; (3):15–21 (in Russian).  
[52] Kimura N, Dota K, Araya Y, Ishidate T, Ishizaka M. Scoring system for differential 
diagnosis of malignant mesothelioma and reactive mesothelial cells on cytology 
specimens. Diagn Cytopathol 2009 ; 37 (12): 885–890.  
[53] Klaassen Z, Lehrhoff BJ. Malignant Mesothelioma of the Tunica Vaginalis Testis: A 
Rare, Enigmatic Tumor. UroToday Int J 2010; 3(6). 
[54] Klimanova Z F. Tumor processes of the serous membranes (for exudates of the serous 
cavities). In: A guide to the cytological diagnosis of human tumors / AS Petrova, MP 
Ptokhov (Eds). Moscow: Publishing House "Meditsina" 1976; 279–301 (in Russian). 
[55] Kroczynska B, Cutrone R, Boccheta M, Yang H, Elmishad AG, Vacek P, Ramos-Nino M, 
Mossman BT, Pass HI, Carbone M. Crocidolite asbestos and SV40 are cocarcinogens 
in human mesothelial cells and in causing mesothelioma in hamsters. Proc Natl 
Acad Sci USA 2006; 103: 14128-14133. 
[56] Kuzaka B, Biernacka-Wawrzonek D, Szymanska K, et al. Adenomatoid tumors of the 
testis and epididymis. Przegl Lek 2004 ; 61: 531–534.  
[57] Lee SC, Lee JK. A case of primary malignant mesothelioma of tunica vaginalis testis. 
Korean J Urol. 1991; 32: 843–845. 
www.intechopen.com
Mesotheliomas – Synonyms and Definition, Epidemiology, Etiology,  
Pathogenesis, Cyto-Histopathological Features, Clinic, Diagnosis, Treatment, Prognosis 
 
68
[58] Liguori G, Garaffa G, Trombetta C, Bussani R, Bucci S, Belgrano E. Inguinal recurrence 
of malignant mesothelioma of the tunica vaginalis: one case report with delayed 
recurrence and review of the literature. Asian J Androl 2007; 9 (6): 859–860.  
[59] Likhachev YuP, Shtern RD. Tumors of the testis, seminal vesicles and penis. In: A guide 
to the pathoanatomical diagnosis of human tumors /NA Kraevsky, A.V 
Smoliyannikov (Eds). Moscow: "Meditsina", 1971; 258–277 (in Russian).  
[60] Livingstone RR, Sarembock LA. Testicular tumours in children. S Afr Med J 1986; 70 (3): 
168–169. 
[61] Mak CW, Cheng TC, Chuang SS, Wu RH, Chou CK, Chang JM. Malignant 
mesothelioma of the tunica vaginalis testis. Br J Radiol 2004; 77: 780–781.  
[62] Malignant mesothelioma edited by Andrea Tannapfel. Springer-Verlag 2011 ; 193 p. 
[63] Malignant mesothelioma: advances in pathogenesis, diagnosis, and translational 
therapies edited by Harvey I Pass, Nicholas J Vogelzang, and Michele Carbone. 
New York, NY: Springer 2005; 854 p.  
[64] Manual of Urology: In three volumes. Vol. 3. In: Testicular tumors. Chapter 23; 317–348; 
Tumors of the testicular epididymis. Chapter 24; 349–350; Tumors of the spermatic 
cord. Chapter 25; 351–353 / Prof. NA.Lopatkin (Ed). Moscow: Publishing House 
“Meditsina” 1998; 672 p (in Russian).  
[65] Marchevsky AM. Application of immunohistochemistry to the diagnosis of malignant 
mesothelioma. Arch Pathol Lab Med 2008; 132: 397–401.  
[66] Marinbakh EB. Malignant tumors of the testis (clinic, diagnosis and treatment): Abstract 
of thesis. … Doctor of Medical Sciences. Moscow 1970; 25 p (in Russian). 
[67] Marinbakh EB. Tumors of the testis and its epididymis. Moscow: Publishing House 
“Meditsina” 1972; 216 p (in Russian).  
[68] Masson P. Tumeurs Humaines. Histologie Diagnostics et Techniques. Paris: Librairie 
Maloine 1956. 
[69] Masson P. Tumeurs Humaines. Histologie Diagnostics et Techniques. Translated from 
the French Prof. SA Vinogradova / AI Strukov (Ed). Moscow: Publishing House 
“Meditsina” 1965; 108–110; 308 (in Russian). 
[70] Matsuzaki K, Nakajima T, Katoh T, Kitoh H, Mizoguchi K, Akahara K, Inone T. 
Malignant mesothelioma of the tunica vaginalis : a case report. Hinyokika Kiyo 
2008; 54 (9): 629–631.  
[71] McElvenny DM, Darnton AJ, Price MJ, Hodgson JT. Mesothelioma mortality in Great 
Britain from 1968 to 2001. Occup Med (Lond) 2005; 55: 79–87.  
[72] Melloni G, Puglisi A, Ferraroli GM, Carretta A, et al. Il trattamento del mesotelioma 
pleurico maligno. Minerva chir 2001; 56 (3):243–250. 
[73] Mesothelioma edited by Bruce WS Robinson and A Philippe Chahinian. London: 
Martin Dunitz 2002; 366 p. 
[74] Mikuz G, Hopfel-Kreiner I. Papillary mesothelioma of the tunica vaginalis propria 
testis. Virchows Archiv 1982; 396 (2): 231–238.  
[75] Moore AJ, Parker RJ, Wiggins J. Malignant mesothelioma. Orphanet J Rare Dis. 2008; 3: 34. 
[76] Morikawa Y, Ishihara Y, Yanase Y, et al. Malignant mesothelioma of tunica vaginalis 
with squamous differentiation. J Urol Pathol 1994; 2: 95–102. 
[77] Mossman BT, Gruenert DC. SV 40, growth factors, and mesothelioma; another piece of 
the puzzle. Am J Respir Cell Mol Biol 2002 ; 26 (2): 167–170. 
[78] Murai Y. Malignant mesothelioma in Japan : analysis of registered autopsy cases. Arch 
Environ Health 2001; 56: 84–88.  
www.intechopen.com
 
Testicular Mesothelioma 
 
69 
[79] Olkhovskaya IG. Tumors of the testis, seminal vesicles and penis. In: Pathoanatomical 
diagnosis of human tumors. Handbook / NA Kraevsky, AV Smoliyannikov, DS 
Sarkisov (Eds). - 3rd Edition. Moscow: "Meditsina" 1982; 296–312 (in Russian).  
[80] Park HM, Kim JH, Bae SG, Kwon TK, Chung SK. A case of malignant mesothelioma of 
tunica vaginalis. Korean J Urol. 1997; 38: 1132–1134. 
[81] Park YJ, Kong HJ, Jang HC, Shin HS, Oh HK, Park JS. Malignant mesothelioma of the 
spermatic cord. Kor J Urol 2011; 52 (3): 225–229.  
[82] Pathology of malignant mesothelioma edited by Franсoise Galateau-Salle. Springer-
Verlag London 2010; 198 p. 
[83] Perez-Ordonez B, Srigley JR. Mesothelial lesions of the paratesticular region. Semin 
Diagn Pathol 2000 ; 17: 294–306. 
[84]  Peto J, Decarli A, Vecchia CLa, Levi F, Negri E. The European mesothelioma epidemic. 
Br J Cancer 1999; 79 (3–4): 666–672.  
[85] Peto J, Hodgson JT, Matthews FE, Jones JR. Continuing increase in mesothelioma 
mortality in Britain. Lancet 1995; 345: 535–539.  
[86] Plas E, Riedl CR, Pflüger H. Malignant mesothelioma of the tunica vaginalis testis: 
review of the literature and assessment of prognostic parameters. Cancer. 
1998;83:2437–2446. 
[87] Reynards JM, Hasan N, Baithun SI, Neuman L, Lord MG. Malignant mesothelioma of 
the tunica vaginalis testis. Br J Urol 1994; 74: 389-390. 
[88] Rekhi B, Pathuthara S, Ajit D, Kake SV. «Signet-ring» cells – A caveat in the diagnosis of 
a diffuse peritoneal mesothelioma occuring in a lady presenting with recurrent 
ascites: An unusual case report. Diagn Cytopathol 2010; 38 (6): 435–439.  
[89] Roggli VL, Pratt PC, Brody AR. Asbestos fiber type in malignant mesothelioma : an 
analytical scanning electron microscopic study of 94 cases. Am J Ind Med 1993 ; 23 
(4): 605–614. 
[90] Roggli VL, Vollmer RT, Butnor KJ, Sporn TA. Tremolite and mesothelioma. Ann Occup 
Hyg 2002 ; 46 (5): 447–453.  
[91] Sabo-Attwood T, Ramos-Nino M, Mossman BT. Environmental Carcinogenesis. 
Chapter 18; P.233–243 In: Section Two Translational Basic Science / Oncology. An 
Evidence-Based Approach Edited by Alfred E.Chang, Patricia A.Ganz, Daniel 
F.Hayes, Timothy J.Kinsellla, Harvey I.Pass, Joan H.Schiller, Richard M.Stone, 
Victor J.Strecher. New York: Springer, 2006; 2022 p. 
[92] *Sawada K, Inoue K, Ishihara T, Kurabayashi A, Moriki T, Shuin T. Multicystic 
malignant mesothelioma of the tunica vaginalis with an unusually indolent clinical 
course. Hinyokika Kiyo 2004; 50 (7): 511–513.  
[93] *Schure PJ, van Dalen KC, Ruitenberg HM, van Dalen T. Mesothelioma of the tunica 
vaginalis testis: a rare malignancy mimicking more common inguino-scrotal 
masses. J Surg Oncol 2006; 94 (2): 162–164.  
[94] Shimada S, Ono K, Suzuki Y, Mori N. Malignant mesothelioma of the tunica vaginalis 
testis: a case with a predominant sarcomatous component. Pathol Int 2004; 54 (12): 
930–934.  
[95] Shin TK, Lee TY, Park MH. Mesothelioma of the tunica vaginalis of the spermatic cord 
with coincidental finding renal cell carcinoma. Korean J Urol. 1995; 36: 1142–1146. 
[96] Smoliyannikov AV. Tumors of serous membranes. In: A guide to the pathoanatomical 
diagnosis of human tumors /NA Kraevsky, A.V Smoliyannikov (Eds). Moscow: 
"Meditsina" 1971; 77–79 (in Russian).  
[97] Spiess PE, Tuziak T, Kassouf W, Grossman HB, Czerniak B. Malignant mesothelioma of 
the tunica vaginalis. Urology 2005; 66: 397–401.  
www.intechopen.com
Mesotheliomas – Synonyms and Definition, Epidemiology, Etiology,  
Pathogenesis, Cyto-Histopathological Features, Clinic, Diagnosis, Treatment, Prognosis 
 
70
[98] Stathopoulos J, Antoniou D, Stathopoulos GP, Rigatos SK, Dimitroulis J, Koutandos J, 
Michalopolou P, Athanasiades A, Veslemes M. Mesothelioma: Treatment and 
survival of a patient population and review of the literature. Anticancer Res 2005; 
25 (5): 3671–3676. 
[99] *Strukov AI, Serov VV. Pathological anatomy. Textbook. Moscow: Publishing House 
"Meditsina" 1979; 188–189 (in Russian). 
[100] Thomas C, Hansen T, Thuroff JW. Malignant mesothelioma of the tunica vaginalis 
testis. Urologe A 2007; 46 (5): 538–540.  
[101] Tolhurst SR, Lotan T, Rapp DE, Lyon MB, Orvieto MA, Gerber GS, Sokoloff MH. Well-
differentiated papillary mesothelioma occurring in the tunica vaginalis of the testis 
with contralateral atypical mesothelial hyperplasia. Urol Oncol: Semin Orig Invest 
2006; 24 (1): 36–39.  
[102] Torbati PM, Parvin M, Ziaee SA. Malignant Mesothelioma of the Spermatic Cord: Case 
Report and Review of the Literature. Urol J 2005; 2: 115–117.  
[103] Tuttle Jr JP, Rous SN, Harrold MW. Mesotheliomas of spermatic cord. Urology 1977; 
10: 466–468. 
[104] Urology: Textbook / Prof. NA Lopatkin (Ed). Fifth Edition, revised and enlarged. 
Moscow: GEOTAR-MED, 2002; 520 p (in Russian). 
[105] van Poppel H, van Renterghem K, Claes H, et al. Benign Mesothelioma of the 
Epididymis: Case Report. Urol Int 1988; 43: 370–371. 
[106] World Health Organization Classification of Tumours. Pathology and Genetics of 
Tumours of the Lung, Pleura, Thymus and Heart / WD Travis, E Brambilla, HK 
Muller-Hermelink, CC Harris (Eds). International Agency for Research on Cancer 
Press. Lyon, 2004 ; 344 p. 
[107] World Health Organization Classification of Tumours. Pathology and Genetics of 
Tumours of the Urinary System and Male Genital Organs / John N Eble, Guido 
Sauter, Jonathan I Epstein, Isabell A Sesterhenn (Eds). International Agency for 
Research on Cancer Press. Lyon, 2004; 359 p. 
[108] Xiao SY, Rizzo P, Carbone M. Benign papillary mesothelioma of the tunica vaginalis 
testis. Arch Pathol Lab Med 2000; 124: 143-147. 
[109] Ya TD, Welch L, Black D, Sugarbaker PH. A systemic review on the efficacy of 
cytoreductive surgery combined with perioperative intraperitoneal chemotherapy 
for diffuse malignancy peritoneal mesothelioma. Ann Oncol 2007; 18 (5): 827–834. 
[110] Zaridze DG. Cancer prevention. Guide for physicians. Moscow: IMA-PRESS 2009; 224 p.  
[111] Zerbino DD, Dmitruk IM. Aetiology, pathogenesis and clinico- morphological 
peculiarities of mesothelioma: A review of the literature. Vrach Delo 1984; (10): 4–8 
(in Russian).  
[112] Zervos MD, Bizekis C, Pass HI. Malignant mesothelioma 2008. Curr Opin Pulm Med 
2008; 14: 303–309. 
[113] Zubritsky AN. Mesothelioma. Principal bibliographic index of Russian and foreign 
literature. Moscow: Meditsina Publishers, 2004; 64 p (in Russian). 
[114] Zubritsky AN. Mesothelioma revisited. Acta Medica Bulgarica 2008; 35(2): 31–34.  
[115] Zubritsky AN. Mesothelioma (a review of the literature). Present Interests of 
Pathological Anatomy: Proceedings. The 3rd Congress of Russian Society of 
Pathologists, Samara, May 26–30, 2009 / Phedorina TA (Ed). Samara, 2009; 2: 604–
605 (in Russian). 
[116] Zubritsky AN. Multiple primary tumours. Bibliographical index of Russian and 
foreign literature. Moscow: “Kalina” 2010; 112 p (in Russian).   
www.intechopen.com
Mesotheliomas - Synonyms and Definition, Epidemiology,
Etiology, Pathogenesis, Cyto-Histopathological Features, Clinic,
Diagnosis, Treatment, Prognosis
Edited by Dr Alexander Zubritsky
ISBN 978-953-307-845-8
Hard cover, 244 pages
Publisher InTech
Published online 03, February, 2012
Published in print edition February, 2012
InTech Europe
University Campus STeP Ri 
Slavka Krautzeka 83/A 
51000 Rijeka, Croatia 
Phone: +385 (51) 770 447 
Fax: +385 (51) 686 166
www.intechopen.com
InTech China
Unit 405, Office Block, Hotel Equatorial Shanghai 
No.65, Yan An Road (West), Shanghai, 200040, China 
Phone: +86-21-62489820 
Fax: +86-21-62489821
Mesotheliomas are mysterious mesothelial tumors in that they are relatively rare, difficult to diagnose, with a
large number of synonyms, and the etiology and pathogenesis of the disease are still not fully disclosed. This
problem attracts the attention of various specialists in the field of medicine and biology every year. In recent
years there has been a significant increase of mesothelioma morbidity in most of the countries, due to the
further industrialization of society. In this regard, this book has been published with the participation of an
international group of experts with rich experience from around the world . The book consists of 14 chapters
containing the most advanced achievements of all aspects of the various types of mesotheliomas, both in
humans and domestic animals, at a high methodological level. This book is intended for biologists and all
health care workers, mostly oncologists of different profiles, as well as students of medical educational
institutions engaged or even just interested in the problems of mesotheliomas.
How to reference
In order to correctly reference this scholarly work, feel free to copy and paste the following:
Alexander N. Zubritsky (2012). Testicular Mesothelioma, Mesotheliomas - Synonyms and Definition,
Epidemiology, Etiology, Pathogenesis, Cyto-Histopathological Features, Clinic, Diagnosis, Treatment,
Prognosis, Dr Alexander Zubritsky (Ed.), ISBN: 978-953-307-845-8, InTech, Available from:
http://www.intechopen.com/books/mesotheliomas-synonyms-and-definition-epidemiology-etiology-
pathogenesis-cyto-histopathological-features-clinic-diagnosis-treatment-prognosis/testicular-mesothelioma
© 2012 The Author(s). Licensee IntechOpen. This is an open access article
distributed under the terms of the Creative Commons Attribution 3.0
License, which permits unrestricted use, distribution, and reproduction in
any medium, provided the original work is properly cited.
